112 investors were named in the funding rounds of 32 private Italian healthcare startups between 16 Nov 2024 and 16 Nov 2026: biotech, medtech, diagnostics, digital health and care services. Not a logo wall: every investor here is on the map because a round names it, and every startup links to that round’s source.
Of the 32 rounds whose investors we can place, 21 were Italian money only and 11 had at least one foreign investor. Italian investors led 22 rounds, foreign investors 5. Italian or foreign is the investor’s headquarters.
Ranked by Italian healthcare startups backed: one per investor and startup, from a round in the window that names the investor; then by rounds and rounds led. A firm’s funds and SGR count as the firm (Indaco Bio is Indaco; CDP Venture Capital’s Technology Transfer and Digital Transition funds are CDP Venture Capital). The rounds shown are each investor’s most recent.
93 more investors backed one startup each; all appear in the rounds table below.
Rounds by the label their reporting gives them. Most Italian healthcare rounds are seed or Series A; a handful of later biotech rounds carry most of the money.
The largest rounds in the window by disclosed amount, converted to US dollars.
Amgen Ventures, Athos Capital, Atlas Venture, CDP Venture Capital, Columbia IMC, Forbion and 7 more
CDP Venture Capital, EIC Fund, Panakès Partners, Sofinnova Partners, XGEN Venture
4BIO Capital, Angelini Ventures, CDP Venture Capital, CE Ventures, Club degli Investitori, Evotec SE and 6 more
Eureka! Venture SGR, Fondazione ENEA Tech e Biomedical, Indaco Venture Partners, New Frontier, Wallaby
CDP Venture Capital, Claris Ventures, Fondazione ENEA Tech e Biomedical, Indaco Venture Partners
F3F, Fondazione ENEA Tech e Biomedical, Indaco Venture Partners, Innogest Capital, TNBT Capital, Wille Finance
All 32 rounds this report counts, newest first, with every investor the reporting names and the source.
| Startup | Round | Amount | Date | Led by | All investors named | Source |
|---|---|---|---|---|---|---|
| Dialybrid | Series A | $17M | 7 Oct 2026 | XGEN Venture | CDP Venture Capital, XGEN Venture | source |
| Aptadir Therapeutics | Seed | $45M | 28 Sept 2026 | 4BIO Capital, CE Ventures | 4BIO Capital, Angelini Ventures, CDP Venture Capital, CE Ventures, Club degli Investitori, Evotec SE, EXTEND, EXTEND co-investors, Indaco Venture Partners, Italian Angels for Biotech, Kerna Ventures, XGEN Venture | source |
| Comestai | Pre-Seed | $2M | 6 Sept 2026 | Vertis SGR | A4W, Club degli Investitori, Martina Domenicali, Paolo Galvani, Selected Investments, Silvia Goggi, Urban Group, Vertis SGR | source |
| Holifya | — | $2M | 1 Sept 2026 | CDP Venture Capital | 20Fund, AC75, CDP Venture Capital, Doorway, Growth Engine, Zooga VC | source |
| Golgenia | Series A | $2M | 28 Jul 2026 | Creadd | Creadd, Indaco Venture Partners, Ruby Direct | source |
| Doctorsa | Seed | $1M | 1 Jul 2026 | PranaVentures | 40Jemz Ventures, PranaVentures, Vento (Exor Ventures) | source |
| Ema Health | Seed | $3M | 17 Jun 2026 | 360 Capital, CDP Venture Capital | 360 Capital, Adolfo Vannucci, Angelini Ventures, Cassa Depositi e Prestiti – Venture Capital SGR, Cassa Depositi e Prestiti Venture Capital, CDP Venture Capital, Ciapa Rosso, Fin+Tech, H-Farm, Massimo Protti, Sebastiano Cavalieri Ducati, Serra Elizabeth Falk, Stefano Barrese, Studio Necchio, Vitaliano Borromeo Arese Borromeo | source |
| WISE | Series D | $35M | 17 Jun 2026 | — | Eureka! Venture SGR, Fondazione ENEA Tech e Biomedical, Indaco Venture Partners, New Frontier, Wallaby | source |
| Niino | Pre-Seed | $1M | 1 Jun 2026 | — | 40Jemz Ventures, Alessandro Braga, Danila De Stefano, Fabrizio Perrone, Francesco Zaccariello, Massimiliano Squillace, Michele Grazioli | source |
| Cellply | — | $8M | 11 May 2026 | Fondazione ENEA Tech e Biomedical | CDP Venture Capital, Fondazione ENEA Tech e Biomedical | source |
| TeiaCare | — | $8M | 8 Apr 2026 | P101 | Inderhabs Capital, Namarel, P101 | source |
| Wearable Robotics | Series A | $6M | 2 Apr 2026 | CDP Venture Capital | CDP Venture Capital, Fondazione Caript, Fondazione Cassa di Risparmio di Lucca, Fondazione CR Firenze, Fondazione Monte dei Paschi di Siena, LIFTT, MITO Technology, RoboIT, SIMEST, Toscana Next | source |
| CiaoDott | Pre-Seed | $2M | 16 Mar 2026 | The Techshop, The Techshop SGR | ALPHA, Club degli Investitori, Growth Engine, The Techshop, The Techshop SGR, Vento (Exor Ventures), Vento (Exor) | source |
| Qura | Pre-Seed | $2M | 3 Mar 2026 | United Ventures | Italian Angels for Growth, United Ventures, Vento (Exor Ventures) | source |
| UpSurgeOn | Series A | $5M | 1 Mar 2026 | CDP Venture Capital | Azimut Libera Impresa SGR, CDP Venture Capital, Deep Blue Ventures, SIMEST | source |
| GenoGra | Pre-Seed | $1M | 15 Feb 2026 | Maia Ventures | Maia Ventures, PM Holding, Terra Next | source |
| LianeCare | Seed | $1M | 9 Jan 2026 | Apside, Zest Investments | Apside, Zest Investments | source |
| Robin Health | Pre-Seed | $2M | 1 Jan 2026 | Step Fund (ACP SGR) | Step Fund (ACP SGR) | source |
| Haptena Therapeutics | Seed | $4M | 16 Dec 2025 | Claris Ventures | Claris Ventures | source |
| Lever Bio | Seed | $6M | 1 Dec 2025 | — | Claris Ventures, Club degli Investitori, Italian Angels for Growth, Ora Global | source |
| AAVantgarde Bio | Series B | $141M | 3 Nov 2025 | Atlas Venture, Forbion, Schroders | Amgen Ventures, Athos Capital, Atlas Venture, CDP Venture Capital, Columbia IMC, Forbion, Longwood Fund, Neva SGR, Schroders, Sixty Degree Capital, Sofinnova Partners, Willett Advisors, XGEN Venture | source |
| NanoPhoria | Series A | $90M | 1 Oct 2025 | CDP Venture Capital, Sofinnova Partners, XGEN Venture | CDP Venture Capital, EIC Fund, Panakès Partners, Sofinnova Partners, XGEN Venture | source |
| Serenis | Series A | $14M | 30 Sept 2025 | Angelini Ventures | Angelini Ventures, Azimut Libera Impresa SGR, CDP Venture Capital, Club degli Investitori, Doorway, FG2 Capital, Invictus Capital, Lumen Ventures, X-Equity Venture Club | source |
| Recornea | Seed | undisclosed | 23 Jul 2025 | — | Fondazione ENEA Tech e Biomedical | source |
| IAMA Therapeutics | Series B | $17M | 16 Apr 2025 | Indaco Venture Partners | CDP Venture Capital, Claris Ventures, Fondazione ENEA Tech e Biomedical, Indaco Venture Partners | source |
| Medicud | Seed | $1M | 9 Apr 2025 | CHMBR Partners | 50 Partners Health, Business Angels des Grandes Ecoles, CHMBR Partners | source |
| MgShell | Seed | $1M | 1 Apr 2025 | Andrea Giani, Capital Cell | Andrea Giani, Bios Line Holding, Capital Cell, Club degli Investitori, Italian Angels for Biotech, Simon Fiduciaria | source |
| Relief | Seed | undisclosed | 5 Mar 2025 | Panakès Partners | Club degli Investitori, Panakès Partners, Santex, Vento (Exor Ventures) | source |
| Newronika | Series B | $14M | 13 Feb 2025 | Fondazione ENEA Tech e Biomedical | F3F, Fondazione ENEA Tech e Biomedical, Indaco Venture Partners, Innogest Capital, TNBT Capital, Wille Finance | source |
| Approxima | Series A | $8M | 1 Feb 2025 | Fondazione ENEA Tech e Biomedical, Panakès Partners | Club degli Investitori, Fondazione ENEA Tech e Biomedical, Panakès Partners | source |
| Tes Pharma | Series A | $5M | 19 Dec 2024 | XGEN Venture | Indaco Venture Partners, XGEN Venture | source |
| BetaGlue | — | $6M | 16 Dec 2024 | LIFTT, Neva SGR | FinPosillipo (Petrone Group), Fondazione ENEA Tech e Biomedical, LIFTT, Mr Giovanni Cerutti, Neva SGR, Romed | source |
Rebuilt every night from our funding-round data over a trailing 24-month window, so a new round appears the morning after we record it. A dated edition stays at its own address: this one.
Lists of “who invests in” a sector are usually drawn from investor databases, where a firm appears because it says the sector is a focus. This one is drawn from the rounds themselves: a firm appears only when a round in the window names it, which is why some well-known names are absent and some unexpected ones are present.
Private companies headquartered in Italy in our health and life-sciences landscape (biopharma, medical devices, diagnostics, digital health, care delivery), plus companies we checked by hand. A random sample of 30 Italian members, read by hand, held 29 health companies; the one miss was a German company filed as Italian and is left out. Listed companies and private-equity deals are not counted.
Equity rounds announced between 16 Nov 2024 and 16 Nov 2026, with articles about the same round merged (45 days), and without grants and debt. Euro amounts are converted at the rate the source gave or near the announcement date. Before the first edition we searched the Italian and international press for the period’s healthcare rounds and added the ones our data did not hold, each with its source.
Every investor a round names, matched to one firm across spellings and funds (Panakès and Panakes, CDP Venture Capital and CDP Venture Capital SGR). A link we judged to belong to a different company of the same name is dropped. “Led” counts only rounds whose reporting names a lead. Grant programmes (EIC Accelerator grants, regional grants) are not investors here; the EIC Fund’s equity is.
Xcout Intel, Who invests in Italian healthcare startups, edition 16 Nov 2026. Data: intel.xcout.app/insights/italy-health-investors?edition=2026-11-16.
You may quote, chart and report on these figures at no charge, with attribution: Source: Xcout Intel Who invests in Italian healthcare startups (intel.xcout.app/insights/italy-health-investors). Reproducing a chart or table needs a link back to this page. Full terms are on the attribution page; how the data is collected is on the methodology page.
Writing about this? We will confirm a figure before you publish and can send the cut behind any number here, by company, country or sector: hello@intel.xcout.app.